top of page
RESEARCH
Prof Todsen’s research focuses on advancing patient-centered care through clinical innovation, translational research, and technology-driven solutions. His work integrates minimally invasive surgical techniques, advanced 3D imaging, multiomics, multimodal AI, and immunological approaches to improve diagnostic precision, treatment outcomes, and quality of life for patients with cancers and infectious diseases. A key aspect of his research is the translation of emerging technologies into clinical practice, including image-guided interventions, transoral robotic surgery (TORS), and immunotherapy-related methodologies.
Read more about the SURGiC research group at Rigshospitalet
See the Prof Todsen Curriculum Vitae (CV)
and publication list
INNOVATION
Professor Todsen’s research and innovation are driven by translating emerging technologies into clinically meaningful solutions that address patients' real clinical needs. A central component of his innovation portfolio is the development novel medical technologies and he has several patents pending. This includes 3Sonic, a next-generation ultrasound-based platform designed to improve precision in cancer surgery. 3Sonic is a spinout company from SURGiC that has been selected as part of BioInnovation Institute (BII) venture lab cohort including 0.5M Euro Grant.
In another project, Prof Todsen has developed the 360MedQuest virtual reality (VR) app together with Associate Professor Joanna Bergström from the Department of Computer Science. The software application integrates 360VR videos with MCQs to provide efficient simulation training for healthcare professionals. See publication 🔗
In addition, Prof Todsen is actively involved in Lifeline Robotics, contributing to the advancement of robotic and automated solutions that improve procedural safety, scalability, and access to high-quality remote care.
Prof Todsen's research group has close collaboration with industry and academic partners to improve rigorous validation, regulatory readiness, and real-world clinical impact, ensuring that new medtech technologies move efficiently from concept to bedside.
bottom of page